1. 2870 Prospective evaluation of both plasma Epstein Barr Virus (EBV) DNA clearance and fludeoxyglucose-positron emission tomography (PET-CT) as a dual-endpoint in predicting early response and survival of patients undergoing chemotherapy (chemo) for advanced nasopharyngeal carcinoma (NPC) (NCT01365208). (September 2015) Authors: Ma, B.; Leung, S.F.; Hui, E.P.; King, A.D.; Wang, K.; Mo, F.; Li, L.; Loong, H.; Kam, M.; Chan, A.; Wong, S.C.C.; Chan, A.T.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-003: What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis. (February 2015) Authors: Blanchard, P.; Lee, A.; Leclercq, J.; Ma, J.; Chan, A.T.C.; Huang, P.Y.; Zhu, G.; Mai, H.Q.; Bourhis, J.; Pignon, J.P. Journal: Radiotherapy and oncology Issue: Volume 114(2015:Jan.)Supplement 1 Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma – What Cut-off Values Should We Use?. Issue 2 (February 2019) Authors: Wong, K.C.W.; Ng, T.Y.; Yu, K.S.; Kwok, J.S.S.; Chan, K.C.A.; Suen, J.J.S.; Leung, S.F.; Chan, A.T.C. Journal: Clinical oncology Issue: Volume 31:Issue 2(2019) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗